The closing price of NRx Pharmaceuticals Inc. (NASDAQ: NRXP) was $1.14 for the day, down -6.56% from the previous closing price of $1.22. In other words, the price has decreased by -$0.0800 from its previous closing price. On the day, 857842 shares were traded. NRXP stock price reached its highest trading level at $1.3400 during the session, while it also had its lowest trading level at $1.1000.
Our analysis of NRXP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.60 and its Current Ratio is at 4.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 17 when Javitt Daniel C. sold 33,018 shares for $1.05 per share. The transaction valued at 34,745 led to the insider holds 9,656,964 shares of the business.
Javitt Daniel C. sold 133,719 shares of NRXP for $136,393 on Nov 16. The 10% Owner now owns 9,689,982 shares after completing the transaction at $1.02 per share. On Nov 11, another insider, Javitt Daniel C., who serves as the 10% Owner of the company, sold 49,200 shares for $1.01 each. As a result, the insider received 49,510 and left with 9,823,701 shares of the company.
Stock Price History:
Over the past 52 weeks, NRXP has reached a high of $10.39, while it has fallen to a 52-week low of $0.49. The 50-Day Moving Average of the stock is 0.8089, while the 200-Day Moving Average is calculated to be 1.3311.
NRXP traded an average of 292.72K shares per day over the past three months and 517.18k shares per day over the past ten days. A total of 65.73M shares are outstanding, with a floating share count of 38.29M. Insiders hold about 1.70% of the company’s shares, while institutions hold 7.10% stake in the company. Shares short for NRXP as of Oct 13, 2022 were 1.47M with a Short Ratio of 1.27M, compared to 1.3M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.17% and a Short% of Float of 3.87%.
The firm’s stock currently is rated by 1 analysts. The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.11 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.56 and -$0.56 for the fiscal current year, implying an average EPS of -$0.56. EPS for the following year is -$0.42, with 1 analysts recommending between -$0.42 and -$0.42.